TrialBMC infectious diseases2025

Parasite clearance and protection from Plasmodium falciparum infection (PCPI): a two-arm, parallel, double-blinded, placebo-controlled, randomised trial of presumptive sulfadoxine-pyrimethamine versus artesunate monotherapy among asymptomatic children 3-5 years of age in Zambia.

Rosario Martinez-Vega et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.